These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2580149)

  • 1. Differential large and small vessel responses to serotonin in the dog hindlimb in vivo: role of the 5HT2 receptor.
    Blackshear JL; Orlandi C; Garnic JD; Hollenberg NK
    J Cardiovasc Pharmacol; 1985; 7(1):42-9. PubMed ID: 2580149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and the renal blood supply: role of prostaglandins and the 5HT-2 receptor.
    Blackshear JL; Orlandi C; Hollenberg NK
    Kidney Int; 1986 Sep; 30(3):304-10. PubMed ID: 3097372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constrictive effect of serotonin on visible renal arteries: a pharmacoangiographic study in anesthetized dogs.
    Blackshear JL; Orlandi C; Hollenberg NK
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):68-73. PubMed ID: 1708058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological analysis of 5-HT-induced vasoconstriction in isolated, perfused dog skeletal muscle arteries.
    Sinanović O; Chiba S
    Eur J Pharmacol; 1987 Nov; 143(3):353-60. PubMed ID: 2891553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that serotonin receptors mediate the cutaneous vasoconstriction produced by 5-hydroxytryptamine in canine forelimbs.
    Dobbins DE; Adamski SW; Lokhandwala MF; Grega GJ
    Circ Res; 1983 Oct; 53(4):473-81. PubMed ID: 6627607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):334-9. PubMed ID: 6482982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-induced vasoconstriction in dog kidney.
    Takahashi T; Hisa H; Satoh S
    J Cardiovasc Pharmacol; 1992; 20(5):779-84. PubMed ID: 1280741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
    Williams BC; Shaikh S; Edwards CR
    J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of isolated canine intermediate auricular arteries to 5-hydroxytryptamine and methysergide.
    Ito T; Chiba S
    Eur J Pharmacol; 1984 Sep; 104(1-2):105-9. PubMed ID: 6499909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific increase in sensitivity to serotonin of the canine hindlimb collateral arterial tree via the 5-hydroxytryptamine-2 receptor.
    Orlandi C; Blackshear JL; Hollenberg NK
    Microvasc Res; 1986 Jul; 32(1):121-30. PubMed ID: 3736444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
    Karasawa A; Kubo K; Shuto K; Nakamizo N
    Jpn J Pharmacol; 1985 Mar; 37(3):285-91. PubMed ID: 3158769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307.
    Verdouw PD; Jennewein HM; Heiligers J; Duncker DJ; Saxena PR
    Eur J Pharmacol; 1984 Jul; 102(3-4):499-509. PubMed ID: 6548449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs.
    Woodman OL
    Br J Pharmacol; 1990 May; 100(1):153-7. PubMed ID: 2372656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by ketanserin of serotonin induced cerebral arteriolar constriction.
    Thompson JA; Wei EP; Kontos HA
    Stroke; 1984; 15(6):1021-4. PubMed ID: 6506113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular responses to serotonin in steroid hypertensive rats.
    Mecca TE; Webb RC
    Hypertension; 1984; 6(6 Pt 1):887-92. PubMed ID: 6519745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.
    Monopoli A; Conti A; Forlani A; Ongini E; Antona C; Biglioli P
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():59-61. PubMed ID: 2285652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of pindolol-induced vasoconstriction in isolated and perfused dog coronary arteries.
    Nakane T; Kawai K; Chiba S
    Jpn J Pharmacol; 1993 May; 62(1):67-74. PubMed ID: 8101886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.